)
Zhinan Xia
Chief Scientific Officer,
Abimmune Bio
Zhinan Xia has more 25 years of Biopharma industrial experience and many years of CGT experience at Moderna, Dynamicure and Abimmune
Sessions
-
17-Jun-2024Salon ATarget selection to avoid off-target effect and cross-reactivity with healthy tissues
-
25-Jun-2024Salon AAddressing heterogeneity challenges using single-cell clonal expansion
-
21-Jun-2024Salon BHow to speed up oligonucleotide drug candidates selection